Skip to main content
Published locations for MR4.5 at imatinib discontinuation improves treatment-free survival in CML
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
MR4.5 at imatinib discontinuation improves treatment-free survival in CML
User login
Username
Password
Reset your password
/content/mr45-imatinib-discontinuation-improves-treatment-free-survival-cml
/hematology-oncology/article/237193/cml/mr45-imatinib-discontinuation-improves-treatment-free